Glycopyrronium Bromide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

63 API Suppliers, 22 USDMF, 9 CEP/COS, 2 JDMF, 6 EU WC, 8 KDMF, 21 NDC API, 36 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

98 Drugs in Development

98 Drugs in Development

FINISHED DOSAGE FORMULATIONS

197 FDF Dossiers, 88 FDA Orange Book, 68 Europe, 13 Canada, 2 Australia, 7 South Africa, 19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 1MG, TABLET;ORAL - 2MG, INJECTABLE;INJECTION - 0.2MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INHALATION - 15.6MCG/INH, POWDER;INHALATION - 15.6MCG/INH;27.5MCG/INH, SOLUTION;INHALATION - 25MCG/ML, TABLET, ORALLY DISINTEGRATING;ORAL - 1.7MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 6 SPI Pharma, 1 DKSH, 4 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 4 Kirsch Pharma, 8 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 10 BASF, 1 CD Formulation, 6 DFE Pharma, 3 Finar, 5 Gangwal Chemicals, 1 Ideal Cures, 3 Ingredion Pharma Solutions, 16 Kerry, 2 Keval Exports, 12 Microlex e.U, 1 Nippon Fine Chemical, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 26 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

54 Fillers, Diluents & Binders, 27 Direct Compression, 21 Granulation, 20 Parenteral, 17 Disintegrants & Superdisintegrants, 15 Thickeners and Stabilizers, 14 Film Formers & Plasticizers, 13 Co-Processed Excipients, 12 Taste Masking, 11 Lubricants & Glidants, 10 Solubilizers, 9 Chewable & Orodispersible Aids, 8 Coating Systems & Additives, 7 Topical, 7 Controlled & Modified Release, 3 Emulsifying Agents, 1 Soft Gelatin, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents, 1 Rheology Modifiers, 1 Dry Powder Inhalation

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 116 News #PharmaBuzz

GLOBAL SALES INFORMATION

32 US Medicaid Prescriptions, 14 Regulatory FDF Prices, 59 Annual Reports

MARKET PLACE

24 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

31 US Patents, 19 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 21 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 17558 / DOSAGE - INJECTABLE;INJECTION - 0.2MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Glycopyrrolate(UNII: V92SO9WP2I) (Glycopyrrolate - UNII:V92SO9WP2I)	Glycopyrrolate	0.2mg in 1

Inactive Ingredients

Ingredient Name	Cardinal Health	General Injectables & Vaccines, Inc
BENZYL ALCOHOL(LKG8494WBH)
HYDROCHLORIC ACID(QTT17582CB)
SODIUM HYDROXIDE(55X04QC32I)
WATER(059QF0KO0R)

Drug Product Composition: Glycopyrronium Bromide